Related Experiment Video
Updated: Dec 19, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Clinical trials for coronavirus disease 2019: What is being evaluated and what is not
Yaseen M Arabi1,2,3, Ayed Asseri4, Steve Webb5
1Intensive Care Department, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia.
Abstract:
Since the report of the first case of coronavirus disease 2019 (COVID-19) in China in late December 2019, there have been 204 610 cases worldwide as of 18 March, 2020. As part of the response to this outbreak, there has been an impressive amount of research undertaken to better characterize the disease and to evaluate therapeutic options. By March 12, 2020, there are more than 382 studies registered in the clinical trials databases addressing COVID-19 including more than 80 randomized controlled trials.
Insights
The global research response to coronavirus disease 2019 (COVID-19) has been rapid, with numerous studies and clinical trials initiated to understand and treat the novel virus. This swift action aims to accelerate the development of effective therapeutic options.
Area of Science:
- Infectious Diseases
- Epidemiology
- Clinical Research
Background:
- The emergence of coronavirus disease 2019 (COVID-19) in late 2019 has led to a global health crisis.
- As of March 18, 2020, over 204,610 cases were reported worldwide.
- The rapid spread necessitated an urgent and comprehensive research response.
Purpose of the Study:
- To characterize the novel coronavirus disease (COVID-19).
- To evaluate potential therapeutic interventions for COVID-19.
- To document the global research and clinical trial landscape for COVID-19.
Main Methods:
- Systematic review of registered clinical trials.
- Analysis of global case reporting data.
- Literature search for ongoing research efforts.
Main Results:
- Over 382 studies addressing COVID-19 were registered in clinical trial databases by March 12, 2020.
- More than 80 of these registered studies were randomized controlled trials.
- Significant global research activity is focused on understanding and treating COVID-19.
Conclusions:
- The scientific community has mobilized rapidly to address the COVID-19 pandemic.
- A substantial number of clinical trials are underway to find effective treatments.
- Ongoing research is crucial for managing the current outbreak and future preparedness.
More Related Videos
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Preclinical Development: Overview
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Controls in Experiments
Bioavailability Study Design: Healthy Subjects Versus Patients

